IUHSA
DNLI icon

Itau Unibanco Holding S.A.’s Denali Therapeutics DNLI Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-268
Closed -$6.17K – 537
2023
Q1 		$6.17K Hold
268
– – ﹤0.01% 472
2022
Q4 		$7.45K Sell
268
-1,130
-81% -$33.6K ﹤0.01% 474
2022
Q3 		$43K Sell
1,398
-553
-28% -$18K ﹤0.01% 399
2022
Q2 		$57K Buy
1,951
+3
+0.2% +$79 ﹤0.01% 325
2022
Q1 		$63K Hold
1,948
– – ﹤0.01% 298
2021
Q4 		$88K Buy
1,948
+1,569
+414% +$74.3K ﹤0.01% 227
2021
Q3 		$19K Buy
379
+10
+3% +$564 ﹤0.01% 340
2021
Q2 		$29K Buy
+369
New +$22.8K ﹤0.01% 265

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return